STEM CELLS IN DISEASE MODELLING AND DRUG DISCOVERY
@StemDrug
Inaugural Conference
June 17-18, 2018
#SCDMDD meeting will be held in Melbourne and provide a focus on pharmaceutical applications of stem cell technology.
Approximately 90 percent of clinical trials of new candidate drugs fail. SCDMDD will explore how stem cell technology has the potential to improve disease models for drug discovery. https://t.co/TmEA1s8RPq
James Hudson (@jehudson85): successful predictions of therapeutic toxicity would never have been possible without mature cardiac #organoid models #SCDMDD2018
Recent publications discovered that cells might resist #geneediting with #CrisprCas, making Crispr less efficient for editing the DNA in #stemcells than researchers may have hoped. However, authors say #Crispr remains a promising technology.#
https://t.co/d55eZ6PGyk
Exciting work from Holly Vogas, as she aims to develop better therapeutics for inducing cardiomyocytes regeneration after injury @UQscience #SCDMDD2018#MIPS#MIPSSTEM
"High-throughput functional screening approaches have the ability to rapidly expand our knowledge of human biology and develop novel therapeutics" -Richard Mills @UQscience #SCDMDD2018#MIPS
NPSC’s Paul Andrews is flying the flag in Melbourne at the Stem Cells in Disease Modelling and Drug Discovery conference @StemDrug#scdmdd - great line up of speakers today and tomorrow.
Excited to be at the inaugural @StemDrug Stem Cells in Disease Modelling and Drug Discovery conference @MIPS_Australia! Kicking things off is Christine Mummery of @UniLeiden on #iPSC models of cardiovascular diseases #SCDMDD2018
Now discussed by Meredith Redd from @UQscience and @StemDrug, ischemic heart disease can be treated with a compound isolated from spider venom #SCDMDD2018#MIPSSTEM#UQ
Starting on Sunday, a fantastic line up of international and cutting edge speakers exploring how stem cell technology has he potential to improve disease models for drug discovery. #stemcells#stemcell https://t.co/cyTlps15ry
Approximately 90 percent of clinical trials of new candidate drugs fail. SCDMDD will explore how stem cell technology has the potential to improve disease models for drug discovery. https://t.co/TmEA1s8RPq
Carol Marchetto, Senior Staff Scientist at The Salk Institute for Biological Studies will be speaking at SCDMDD conference, among an international line up of cutting edge researchers in stem cell biology.
Registrations accepted until 6th June. #stemcells#stemcell#MIPS
Lorenz Studer will be speaking at SCDMDD about his work on the use of stem cell technology to understand and treat brain diseases. Still time to register for this event. #stemcells#stemcel#MIPS
The full SCDMDD PROGRAM is now available! Check it out here: https://t.co/8TjsHvnHa1
SCDMDD showcases international leaders and innovative Australian researchers. It will be an exciting and inspiring event. We look forward to welcoming you to MIPS in June. #stemcells#stemcell
Approximately 90 percent of clinical trials of new candidate drugs fail. SCDMDD will explore how stem cell technology has the potential to improve disease models for drug discovery. https://t.co/TmEA1s8RPq
Early Registration closes tomorrow, 17th April AEST. This will be an exciting conference with cutting edge talks by innovative researchers in the stem cell technology field. #stemcell#stemscells#MIPS#Drugdiscovery https://t.co/cyTlps15ry
Approximately 90 percent of clinical trials of new candidate drugs fail. SCDMDD will explore how stem cell technology has the potential to improve disease models for drug discovery. https://t.co/TmEA1s8RPq
Dr Jame Husdon is one of our speakers. Take a look at this most interesting researcher https://t.co/mkvivo2P5N
Early birds expires 17th April. Register here: https://t.co/rEdNrfMLyQ …
#stemcells#stemcell#MIPS#drugdiscovery